Copyright Reports & Markets. All rights reserved.

Global Recombinant Human Annexin A2 Protein Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Recombinant Human Annexin A2 Protein Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 >90%
    • 1.3.3 >95%
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Recombinant Human Annexin A2 Protein Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 ELISA
    • 1.4.3 WB
    • 1.4.4 Antibody Production
    • 1.4.5 Protein Array
    • 1.4.6 Others
  • 1.5 Global Recombinant Human Annexin A2 Protein Market Size & Forecast
    • 1.5.1 Global Recombinant Human Annexin A2 Protein Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Recombinant Human Annexin A2 Protein Sales Quantity (2021-2032)
    • 1.5.3 Global Recombinant Human Annexin A2 Protein Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 R&D Systems
    • 2.1.1 R&D Systems Details
    • 2.1.2 R&D Systems Major Business
    • 2.1.3 R&D Systems Recombinant Human Annexin A2 Protein Product and Services
    • 2.1.4 R&D Systems Recombinant Human Annexin A2 Protein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 R&D Systems Recent Developments/Updates
  • 2.2 Abcam
    • 2.2.1 Abcam Details
    • 2.2.2 Abcam Major Business
    • 2.2.3 Abcam Recombinant Human Annexin A2 Protein Product and Services
    • 2.2.4 Abcam Recombinant Human Annexin A2 Protein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Abcam Recent Developments/Updates
  • 2.3 RayBiotech
    • 2.3.1 RayBiotech Details
    • 2.3.2 RayBiotech Major Business
    • 2.3.3 RayBiotech Recombinant Human Annexin A2 Protein Product and Services
    • 2.3.4 RayBiotech Recombinant Human Annexin A2 Protein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 RayBiotech Recent Developments/Updates
  • 2.4 Elabscience
    • 2.4.1 Elabscience Details
    • 2.4.2 Elabscience Major Business
    • 2.4.3 Elabscience Recombinant Human Annexin A2 Protein Product and Services
    • 2.4.4 Elabscience Recombinant Human Annexin A2 Protein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Elabscience Recent Developments/Updates
  • 2.5 Cusabio
    • 2.5.1 Cusabio Details
    • 2.5.2 Cusabio Major Business
    • 2.5.3 Cusabio Recombinant Human Annexin A2 Protein Product and Services
    • 2.5.4 Cusabio Recombinant Human Annexin A2 Protein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Cusabio Recent Developments/Updates
  • 2.6 enQuire BioReagents
    • 2.6.1 enQuire BioReagents Details
    • 2.6.2 enQuire BioReagents Major Business
    • 2.6.3 enQuire BioReagents Recombinant Human Annexin A2 Protein Product and Services
    • 2.6.4 enQuire BioReagents Recombinant Human Annexin A2 Protein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 enQuire BioReagents Recent Developments/Updates
  • 2.7 Protein Alternatives
    • 2.7.1 Protein Alternatives Details
    • 2.7.2 Protein Alternatives Major Business
    • 2.7.3 Protein Alternatives Recombinant Human Annexin A2 Protein Product and Services
    • 2.7.4 Protein Alternatives Recombinant Human Annexin A2 Protein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Protein Alternatives Recent Developments/Updates
  • 2.8 Labome
    • 2.8.1 Labome Details
    • 2.8.2 Labome Major Business
    • 2.8.3 Labome Recombinant Human Annexin A2 Protein Product and Services
    • 2.8.4 Labome Recombinant Human Annexin A2 Protein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Labome Recent Developments/Updates
  • 2.9 OriGene
    • 2.9.1 OriGene Details
    • 2.9.2 OriGene Major Business
    • 2.9.3 OriGene Recombinant Human Annexin A2 Protein Product and Services
    • 2.9.4 OriGene Recombinant Human Annexin A2 Protein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 OriGene Recent Developments/Updates
  • 2.10 Prospec Bio
    • 2.10.1 Prospec Bio Details
    • 2.10.2 Prospec Bio Major Business
    • 2.10.3 Prospec Bio Recombinant Human Annexin A2 Protein Product and Services
    • 2.10.4 Prospec Bio Recombinant Human Annexin A2 Protein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Prospec Bio Recent Developments/Updates
  • 2.11 Lifespan Biosciences
    • 2.11.1 Lifespan Biosciences Details
    • 2.11.2 Lifespan Biosciences Major Business
    • 2.11.3 Lifespan Biosciences Recombinant Human Annexin A2 Protein Product and Services
    • 2.11.4 Lifespan Biosciences Recombinant Human Annexin A2 Protein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Lifespan Biosciences Recent Developments/Updates
  • 2.12 Hölzel Diagnostika Handels
    • 2.12.1 Hölzel Diagnostika Handels Details
    • 2.12.2 Hölzel Diagnostika Handels Major Business
    • 2.12.3 Hölzel Diagnostika Handels Recombinant Human Annexin A2 Protein Product and Services
    • 2.12.4 Hölzel Diagnostika Handels Recombinant Human Annexin A2 Protein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Hölzel Diagnostika Handels Recent Developments/Updates
  • 2.13 MyBioSource
    • 2.13.1 MyBioSource Details
    • 2.13.2 MyBioSource Major Business
    • 2.13.3 MyBioSource Recombinant Human Annexin A2 Protein Product and Services
    • 2.13.4 MyBioSource Recombinant Human Annexin A2 Protein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 MyBioSource Recent Developments/Updates
  • 2.14 Novus Biologicals
    • 2.14.1 Novus Biologicals Details
    • 2.14.2 Novus Biologicals Major Business
    • 2.14.3 Novus Biologicals Recombinant Human Annexin A2 Protein Product and Services
    • 2.14.4 Novus Biologicals Recombinant Human Annexin A2 Protein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Novus Biologicals Recent Developments/Updates
  • 2.15 BioCrick
    • 2.15.1 BioCrick Details
    • 2.15.2 BioCrick Major Business
    • 2.15.3 BioCrick Recombinant Human Annexin A2 Protein Product and Services
    • 2.15.4 BioCrick Recombinant Human Annexin A2 Protein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 BioCrick Recent Developments/Updates
  • 2.16 AMSBIO
    • 2.16.1 AMSBIO Details
    • 2.16.2 AMSBIO Major Business
    • 2.16.3 AMSBIO Recombinant Human Annexin A2 Protein Product and Services
    • 2.16.4 AMSBIO Recombinant Human Annexin A2 Protein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 AMSBIO Recent Developments/Updates
  • 2.17 ProteoGenix
    • 2.17.1 ProteoGenix Details
    • 2.17.2 ProteoGenix Major Business
    • 2.17.3 ProteoGenix Recombinant Human Annexin A2 Protein Product and Services
    • 2.17.4 ProteoGenix Recombinant Human Annexin A2 Protein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 ProteoGenix Recent Developments/Updates
  • 2.18 Signalway Antibody LLC
    • 2.18.1 Signalway Antibody LLC Details
    • 2.18.2 Signalway Antibody LLC Major Business
    • 2.18.3 Signalway Antibody LLC Recombinant Human Annexin A2 Protein Product and Services
    • 2.18.4 Signalway Antibody LLC Recombinant Human Annexin A2 Protein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Signalway Antibody LLC Recent Developments/Updates
  • 2.19 Amyjet Scientific Inc
    • 2.19.1 Amyjet Scientific Inc Details
    • 2.19.2 Amyjet Scientific Inc Major Business
    • 2.19.3 Amyjet Scientific Inc Recombinant Human Annexin A2 Protein Product and Services
    • 2.19.4 Amyjet Scientific Inc Recombinant Human Annexin A2 Protein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Amyjet Scientific Inc Recent Developments/Updates

3 Competitive Environment: Recombinant Human Annexin A2 Protein by Manufacturer

  • 3.1 Global Recombinant Human Annexin A2 Protein Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Recombinant Human Annexin A2 Protein Revenue by Manufacturer (2021-2026)
  • 3.3 Global Recombinant Human Annexin A2 Protein Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Recombinant Human Annexin A2 Protein by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Recombinant Human Annexin A2 Protein Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Recombinant Human Annexin A2 Protein Manufacturer Market Share in 2025
  • 3.5 Recombinant Human Annexin A2 Protein Market: Overall Company Footprint Analysis
    • 3.5.1 Recombinant Human Annexin A2 Protein Market: Region Footprint
    • 3.5.2 Recombinant Human Annexin A2 Protein Market: Company Product Type Footprint
    • 3.5.3 Recombinant Human Annexin A2 Protein Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Recombinant Human Annexin A2 Protein Market Size by Region
    • 4.1.1 Global Recombinant Human Annexin A2 Protein Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Recombinant Human Annexin A2 Protein Consumption Value by Region (2021-2032)
    • 4.1.3 Global Recombinant Human Annexin A2 Protein Average Price by Region (2021-2032)
  • 4.2 North America Recombinant Human Annexin A2 Protein Consumption Value (2021-2032)
  • 4.3 Europe Recombinant Human Annexin A2 Protein Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Recombinant Human Annexin A2 Protein Consumption Value (2021-2032)
  • 4.5 South America Recombinant Human Annexin A2 Protein Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Recombinant Human Annexin A2 Protein Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Recombinant Human Annexin A2 Protein Sales Quantity by Type (2021-2032)
  • 5.2 Global Recombinant Human Annexin A2 Protein Consumption Value by Type (2021-2032)
  • 5.3 Global Recombinant Human Annexin A2 Protein Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Recombinant Human Annexin A2 Protein Sales Quantity by Application (2021-2032)
  • 6.2 Global Recombinant Human Annexin A2 Protein Consumption Value by Application (2021-2032)
  • 6.3 Global Recombinant Human Annexin A2 Protein Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Recombinant Human Annexin A2 Protein Sales Quantity by Type (2021-2032)
  • 7.2 North America Recombinant Human Annexin A2 Protein Sales Quantity by Application (2021-2032)
  • 7.3 North America Recombinant Human Annexin A2 Protein Market Size by Country
    • 7.3.1 North America Recombinant Human Annexin A2 Protein Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Recombinant Human Annexin A2 Protein Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Recombinant Human Annexin A2 Protein Sales Quantity by Type (2021-2032)
  • 8.2 Europe Recombinant Human Annexin A2 Protein Sales Quantity by Application (2021-2032)
  • 8.3 Europe Recombinant Human Annexin A2 Protein Market Size by Country
    • 8.3.1 Europe Recombinant Human Annexin A2 Protein Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Recombinant Human Annexin A2 Protein Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Recombinant Human Annexin A2 Protein Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Recombinant Human Annexin A2 Protein Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Recombinant Human Annexin A2 Protein Market Size by Region
    • 9.3.1 Asia-Pacific Recombinant Human Annexin A2 Protein Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Recombinant Human Annexin A2 Protein Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Recombinant Human Annexin A2 Protein Sales Quantity by Type (2021-2032)
  • 10.2 South America Recombinant Human Annexin A2 Protein Sales Quantity by Application (2021-2032)
  • 10.3 South America Recombinant Human Annexin A2 Protein Market Size by Country
    • 10.3.1 South America Recombinant Human Annexin A2 Protein Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Recombinant Human Annexin A2 Protein Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Recombinant Human Annexin A2 Protein Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Recombinant Human Annexin A2 Protein Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Recombinant Human Annexin A2 Protein Market Size by Country
    • 11.3.1 Middle East & Africa Recombinant Human Annexin A2 Protein Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Recombinant Human Annexin A2 Protein Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Recombinant Human Annexin A2 Protein Market Drivers
  • 12.2 Recombinant Human Annexin A2 Protein Market Restraints
  • 12.3 Recombinant Human Annexin A2 Protein Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Recombinant Human Annexin A2 Protein and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Recombinant Human Annexin A2 Protein
  • 13.3 Recombinant Human Annexin A2 Protein Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Recombinant Human Annexin A2 Protein Typical Distributors
  • 14.3 Recombinant Human Annexin A2 Protein Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Recombinant Human Annexin A2 Protein market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Recombinant Human Annexin A2 Protein market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Recombinant Human Annexin A2 Protein market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Recombinant Human Annexin A2 Protein market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Recombinant Human Annexin A2 Protein market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Recombinant Human Annexin A2 Protein market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Recombinant Human Annexin A2 Protein
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Recombinant Human Annexin A2 Protein market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include R&D Systems, Abcam, RayBiotech, Elabscience, Cusabio, enQuire BioReagents, Protein Alternatives, Labome, OriGene, Prospec Bio, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Recombinant Human Annexin A2 Protein market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    >90%
    >95%
    Others
    Market segment by Application
    ELISA
    WB
    Antibody Production
    Protein Array
    Others
    Major players covered
    R&D Systems
    Abcam
    RayBiotech
    Elabscience
    Cusabio
    enQuire BioReagents
    Protein Alternatives
    Labome
    OriGene
    Prospec Bio
    Lifespan Biosciences
    Hölzel Diagnostika Handels
    MyBioSource
    Novus Biologicals
    BioCrick
    AMSBIO
    ProteoGenix
    Signalway Antibody LLC
    Amyjet Scientific Inc
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Recombinant Human Annexin A2 Protein product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Recombinant Human Annexin A2 Protein, with price, sales quantity, revenue, and global market share of Recombinant Human Annexin A2 Protein from 2021 to 2026.
    Chapter 3, the Recombinant Human Annexin A2 Protein competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Recombinant Human Annexin A2 Protein breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Recombinant Human Annexin A2 Protein market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Human Annexin A2 Protein.
    Chapter 14 and 15, to describe Recombinant Human Annexin A2 Protein sales channel, distributors, customers, research findings and conclusion.

    Buy now